NEW YORK and SOUTH SAN FRANCISCO, Calif., June 13, 2022 /PRNewswire/ -- Biotech Acquisition Company (NASDAQ:BIOT) ("BAC"), a publicly traded special purpose acquisition company affiliated with SPRIM Global Investments, and Blade Therapeutics, Inc. ("Blade"), a biopharmaceutical company based in South San Francisco, Calif., today announced that they have mutually agreed to terminate the previously announced Agreement and Plan of Merger (the "Merger Agreement"), effective immediately.
Read more at prnewswire.comBiotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination Agreement
/Server%20racks%20by%20dotshock%20via%20Shutterstock.jpg)
/Amazon%20-%20Image%20by%20bluestork%20via%20Shutterstock.jpg)
/Apple%20logo%20-%20by%20Pexels%20via%20Pixabay.jpg)